Redeye comments on the outcome of AlzeCure’s rights issue, which was significantly oversubscribed at...
India returns to growth and margins expand Medicover delivered another strong quarter, beating adj.
Safello has announced a partnership with Marginalen Bank, positioning itself as the first crypto bro...
Redeye provides an update on NextCell following the company’s Q3 report, which came in largely in li...
Net sales and clean EBIT were below market consensus (LSEG) in Q2.
Redeye updates its estimates and valuation following MedCap’s Q2 2025 report.
Q2 results Medicover reported an adj. EBITDA beat in Q2 (+7%/+7% vs.
Physitrack’s Q2 2025 results came in broadly in line with our expectations.
Redeye shares its initial view on Modelon’s Q2 2025 report.
VNV Globals investeringsportfölj steg över 5% sekventiellt mätt i usd, drivet främst av uppvärdering...
Redeye returns with a more in-depth take on the Q2 report.
Bright spot in FMWT Q2 sales were SEK 228m, -3% y-o-y and flat y-o-y in local currencies, while EBIT...
Incap downgraded its full year outlook on 22 July 2025.
Redeye leaves an initial comment on the strong Q2 report, where OPEX cuts and higher distributor sal...
Redeye comments on the takeover bid from OsteoCentric.